Hypoglycemic and beta cell protective effects of andrographolide analogue for diabetes treatment

Abstract

We have demonstrated that AL-1 had both hypoglycemic and beta cell protective effects which translated into antioxidant and NF-kappaB inhibitory activity. AL-1 is a potential new anti-diabetic agent.